J NEUROL 润色咨询

JOURNAL OF NEUROLOGY

出版年份:1974 年文章数:4000 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-11-02 隐形的翅膀

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊

    12

    展开12条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2019-05-21 Janzu2003

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-04-13 隐形的翅膀

    拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2023-06-28 CottonBlue 来自湖北省

    审稿速度:1.0
    经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2020-02-28 1480aa6cm65(暂无昵称)

    投稿命中率:25.0
    经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来)

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-06-10 ms6000000601742295

    with editor 已经一周了,没拒稿也没送审,这啥情况呀

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2014-09-29 bingojean

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。
    而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2021-04-01 ms9000001571807559

    请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-07-05 ms7000001844459526

    7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210867, encodeId=721d121086e41, content=拒稿率90%,但是编辑非常高效,如果稿件质量不错,会推荐转投杂志过来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Apr 13 15:22:13 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225698, encodeId=94bc122569864, content=with editor 已经一周了,没拒稿也没送审,这啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Fri Jun 10 18:14:24 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230636, encodeId=74d9123063621, content=7.3日23:50多投稿submitted to joural,7.5还是这个状态,这个状态会持续多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47a46579484, createdName=ms7000001844459526, createdTime=Tue Jul 05 10:24:43 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198871, encodeId=c1b611988e116, content=一般等多少天,编辑才处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Wed Mar 02 22:05:37 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-03-02 Doc.hcy

    一般等多少天,编辑才处理稿件

    3

    展开3条回复
共109条页码: 1/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分